Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,025,000 | 18,633,000 | 10,475,000 | 4,886,000 | 9,195,000 |
| Depreciation Amortization | 5,191,000 | 3,856,000 | 2,515,000 | 1,207,000 | 4,681,000 |
| Income taxes - deferred | -4,636,000 | -3,610,000 | 137,000 | 203,000 | 2,288,000 |
| Accounts receivable | -3,811,000 | N/A | N/A | N/A | -1,275,000 |
| Other Working Capital | 12,804,000 | 10,867,000 | 4,102,000 | -1,281,000 | -307,000 |
| Other Operating Activity | 1,007,000 | -3,080,000 | -1,392,000 | -477,000 | -179,000 |
| Operating Cash Flow | $32,580,000 | $26,666,000 | $15,837,000 | $4,538,000 | $14,403,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,098,000 | -17,580,000 | -8,915,000 | -1,585,000 | -1,798,000 |
| PPE Investments | -2,711,000 | -1,709,000 | -1,091,000 | -554,000 | -2,226,000 |
| Purchase Of Investment | -1,068,000 | -861,000 | -100,000 | -27,000 | -597,000 |
| Sale Of Investment | 649,000 | 569,000 | 297,000 | 256,000 | 723,000 |
| Other Investing Activity | -318,000 | -379,000 | -75,000 | 163,000 | -373,000 |
| Investing Cash Flow | $-22,546,000 | $-19,960,000 | $-9,884,000 | $-1,747,000 | $-4,271,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -96,000 | 265,000 | -499,000 | -25,000 | 8,223,000 |
| Debt Issued | 997,000 | 997,000 | N/A | N/A | 5,222,000 |
| Debt Repayment | -2,004,000 | -1,001,000 | N/A | N/A | -4,003,000 |
| Dividend Paid | -8,729,000 | -6,540,000 | -4,355,000 | -2,172,000 | -8,440,000 |
| Other Financing Activity | 16,000 | -186,000 | -510,000 | -610,000 | -10,651,000 |
| Financing Cash Flow | $-9,816,000 | $-6,465,000 | $-5,364,000 | $-2,807,000 | $-9,649,000 |
| Exchange Rate Effect | -59,000 | -32,000 | 5,000 | N/A | -8,000 |
| Beginning Cash Position | 1,825,000 | 1,825,000 | 1,825,000 | 1,825,000 | 1,350,000 |
| End Cash Position | 1,983,000 | 2,034,000 | 2,418,000 | 1,809,000 | 1,825,000 |
| Net Cash Flow | $159,000 | $209,000 | $593,000 | $-15,000 | $475,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 32,580,000 | 26,666,000 | 15,837,000 | 4,538,000 | 14,403,000 |
| Capital Expenditure | -2,711,000 | -1,709,000 | -1,091,000 | -554,000 | -2,226,000 |
| Free Cash Flow | 29,869,000 | 24,957,000 | 14,746,000 | 3,984,000 | 12,177,000 |